Product details
Catalog number A02056-3-FITC
Price for A02056-3-FITC
Size / count 100 µg/Vial
Boster Bio Anti-IFNAR2 Antibody Picoband® catalog # A02056-3. Tested in ELISA, Flow Cytometry, IF, IHC, ICC, WB applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
The catalog number for Anti-IFNAR2 Antibody Picoband®, FITC Conjugate is A02056-3-FITC.
Anti-IFNAR2 Antibody Picoband®, FITC Conjugate is available in the following size(s): 100 µg/Vial.
Anti-IFNAR2 Antibody Picoband®, FITC Conjugate is currently made to order / not held in immediate stock. Contact us for lead time.
The safety data sheet for Anti-IFNAR2 Antibody Picoband®, FITC Conjugate is available here: https://www.bosterbio.com/msds?sku=A02056-3.
Boster Bio Anti-IFNAR2 Antibody Picoband® catalog # A02056-3. Tested in ELISA, Flow Cytometry, IF, IHC, ICC, WB applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals w
Some products, including certain cell lines and biologics, require dry ice for transportation, which carries an additional fee shown clearly in your quotation. Dry ice delivery isn’t always possible to every destination due to transit time or local restrictions, so we check feasibility in advance and you must store the goods at the correct temperature the moment they arrive.
Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.
Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.